Indegene

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE065X01017
NSEID: INDGN
BSEID: 544172
View on NSE | View on BSE

INR

500.60

9.55 (1.94%)

BSENSE

Feb 03

BSE+NSE Vol: 5.64 lacs

{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "500.60",
    "chg": 9.55,
    "chgp": "1.94%",
    "dir": 1,
    "prev_price": "491.05",
    "mcapval": "12,092.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "",
    "isin": "INE065X01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "5.64 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indegene-10039241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-technical-momentum-shifts-amid-mixed-market-signals-3817332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndegeneLtd_technicaldot_3817332.png",
        "date": "2026-02-03 08:05:48",
        "description": "Indegene Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a recent 1.55% gain in daily price, the stock faces mixed signals from key momentum and trend indicators, suggesting cautious optimism for investors in the healthcare services sector."
      },
      {
        "title": "Indegene Ltd Gains 1.73%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-gains-173-4-key-factors-driving-the-weeks-volatility-3812331",
        "imagepath": "",
        "date": "2026-01-31 09:03:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock hits 52-week and all-time low near Rs.462</p>\n                    <p><strong>29 Jan:</strong> Q2 FY26 results reveal margin compression despite revenue growth</p>\n                    <p><strong>30 Jan:</strong> Stock falls again to 52-week low of Rs.455.8 amid market pressure</p>\n                    <p><strong>30 Jan:</strong> Week closes at Rs.482.20 (+1.73%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.474.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Are Indegene Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indegene-ltd-latest-results-good-or-bad-3811950",
        "imagepath": "",
        "date": "2026-01-30 19:28:59",
        "description": "Indegene Ltd's latest financial results for Q2 FY26 present a mixed picture. The company reported net sales of ₹804.20 crores, reflecting a sequential growth of 5.70% and a year-on-year increase of 17.09%. This marks the seventh consecutive quarter of positive revenue growth, indicating the company's ability to capture market share within the healthcare services sector. However, the net profit for the quarter was ₹102.10 crores, which represents a sequential decline of 12.29%. \n\nProfitability metrics show a concerning trend, with the operating margin (excluding other income) contracting to 17.48% from 20.41% in the previous quarter, and the PAT margin decreasing to 12.70% from 15.30%. This margin compression suggests challenges in cost management, particularly as employee costs rose significantly, accounting for a larger proportion of revenue compared to prior periods. \n\nDespite these profitability challeng..."
      },
      {
        "title": "Indegene Ltd Falls to 52-Week Low of Rs.455.8 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-falls-to-52-week-low-of-rs4558-amid-market-pressure-3811435",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_priceRelatedfactors_3811435.png",
        "date": "2026-01-30 11:28:59",
        "description": "Indegene Ltd, a key player in the Healthcare Services sector, witnessed its stock price decline to a fresh 52-week low of Rs.455.8 on 30 Jan 2026, marking a significant milestone in its recent trading performance. This new low reflects ongoing challenges in the stock’s trajectory despite some positive financial indicators."
      },
      {
        "title": "Indegene Ltd Q2 FY26: Margin Compression Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/indegene-ltd-q2-fy26-margin-compression-overshadows-revenue-growth-3810207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/Indegene_quaterlyResult_3810207.png",
        "date": "2026-01-29 21:04:03",
        "description": "Indegene Limited, a healthcare services provider with a market capitalisation of ₹11,366 crores, reported net profit of ₹102.10 crores for Q2 FY26, marking a sequential decline of 12.29% from ₹116.40 crores in Q1 FY26, though demonstrating year-on-year growth of 11.34% from ₹91.70 crores in Q2 FY25. The stock has reacted negatively to the results, trading at ₹467.25, down 1.72% from the previous close of ₹475.45, and now sits 27.01% below its 52-week high of ₹640.15."
      },
      {
        "title": "Indegene Ltd Stock Hits All-Time Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-stock-hits-all-time-low-amid-continued-downtrend-3805919",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_priceRelatedfactors_3805919.png",
        "date": "2026-01-27 11:04:40",
        "description": "Indegene Ltd’s stock has declined to an all-time low of Rs.462.3, marking a significant milestone in its recent performance. The healthcare services company has experienced a sustained downward trajectory, underperforming both its sector and broader market indices over multiple time frames."
      },
      {
        "title": "Indegene Ltd Stock Falls to 52-Week Low of Rs.463 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-stock-falls-to-52-week-low-of-rs463-amidst-continued-downtrend-3805839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_priceRelatedfactors_3805839.png",
        "date": "2026-01-27 10:55:16",
        "description": "Indegene Ltd, a key player in the healthcare services sector, has touched a new 52-week low of Rs.463, marking a significant decline amid a sustained downward trend. The stock has underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      },
      {
        "title": "Indegene Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-sell-by-marketsmojo-3802957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_mojoScore_3802957.png",
        "date": "2026-01-24 10:10:39",
        "description": "Indegene Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 January 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Indegene Ltd Stock Falls to 52-Week Low of Rs.471.45 Amidst Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-stock-falls-to-52-week-low-of-rs47145-amidst-underperformance-3796361",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_priceRelatedfactors_3796361.png",
        "date": "2026-01-20 11:30:52",
        "description": "Indegene Ltd, a key player in the Healthcare Services sector, touched a fresh 52-week low of Rs.471.45 today, marking a significant decline in its stock price amid a backdrop of subdued financial results and extended underperformance relative to market benchmarks."
      }
    ],
    "total": 188,
    "sid": "10039241",
    "stock_news_url": "https://www.marketsmojo.com/news/indegene-10039241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jan-2026",
      "details": "Intimation of Newspaper Publication.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "30-Jan-2026",
      "details": "Audio Recording of the Q3FY26 Earnings Call.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results With Limited Review Report",
      "datetime": "29-Jan-2026",
      "details": "Financial results with Limited review report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>100%</strong> dividend, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-03 08:05:48

Indegene Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a recent 1.55% gain in daily price, the stock faces mixed signals from key momentum and trend indicators, suggesting cautious optimism for investors in the healthcare services sector.

Read full news article

Indegene Ltd Gains 1.73%: 4 Key Factors Driving the Week’s Volatility

2026-01-31 09:03:14

Key Events This Week

27 Jan: Stock hits 52-week and all-time low near Rs.462

29 Jan: Q2 FY26 results reveal margin compression despite revenue growth

30 Jan: Stock falls again to 52-week low of Rs.455.8 amid market pressure

30 Jan: Week closes at Rs.482.20 (+1.73%) outperforming Sensex

Week Open

Rs.474.00

Week Close

Read full news article

Are Indegene Ltd latest results good or bad?

2026-01-30 19:28:59

Indegene Ltd's latest financial results for Q2 FY26 present a mixed picture. The company reported net sales of ₹804.20 crores, reflecting a sequential growth of 5.70% and a year-on-year increase of 17.09%. This marks the seventh consecutive quarter of positive revenue growth, indicating the company's ability to capture market share within the healthcare services sector. However, the net profit for the quarter was ₹102.10 crores, which represents a sequential decline of 12.29%. Profitability metrics show a concerning trend, with the operating margin (excluding other income) contracting to 17.48% from 20.41% in the previous quarter, and the PAT margin decreasing to 12.70% from 15.30%. This margin compression suggests challenges in cost management, particularly as employee costs rose significantly, accounting for a larger proportion of revenue compared to prior periods. Despite these profitability challeng...

Read full news article

Indegene Ltd Falls to 52-Week Low of Rs.455.8 Amid Market Pressure

2026-01-30 11:28:59

Indegene Ltd, a key player in the Healthcare Services sector, witnessed its stock price decline to a fresh 52-week low of Rs.455.8 on 30 Jan 2026, marking a significant milestone in its recent trading performance. This new low reflects ongoing challenges in the stock’s trajectory despite some positive financial indicators.

Read full news article

Indegene Ltd Q2 FY26: Margin Compression Overshadows Revenue Growth

2026-01-29 21:04:03

Indegene Limited, a healthcare services provider with a market capitalisation of ₹11,366 crores, reported net profit of ₹102.10 crores for Q2 FY26, marking a sequential decline of 12.29% from ₹116.40 crores in Q1 FY26, though demonstrating year-on-year growth of 11.34% from ₹91.70 crores in Q2 FY25. The stock has reacted negatively to the results, trading at ₹467.25, down 1.72% from the previous close of ₹475.45, and now sits 27.01% below its 52-week high of ₹640.15.

Read full news article

Indegene Ltd Stock Hits All-Time Low Amid Continued Downtrend

2026-01-27 11:04:40

Indegene Ltd’s stock has declined to an all-time low of Rs.462.3, marking a significant milestone in its recent performance. The healthcare services company has experienced a sustained downward trajectory, underperforming both its sector and broader market indices over multiple time frames.

Read full news article

Indegene Ltd Stock Falls to 52-Week Low of Rs.463 Amidst Continued Downtrend

2026-01-27 10:55:16

Indegene Ltd, a key player in the healthcare services sector, has touched a new 52-week low of Rs.463, marking a significant decline amid a sustained downward trend. The stock has underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Read full news article

Indegene Ltd is Rated Sell by MarketsMOJO

2026-01-24 10:10:39

Indegene Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 January 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Indegene Ltd Stock Falls to 52-Week Low of Rs.471.45 Amidst Underperformance

2026-01-20 11:30:52

Indegene Ltd, a key player in the Healthcare Services sector, touched a fresh 52-week low of Rs.471.45 today, marking a significant decline in its stock price amid a backdrop of subdued financial results and extended underperformance relative to market benchmarks.